Danavorexton

DB16962InvestigationalSmall molecule

Danavorexton: Overview.

Chemical structure of Danavorexton
Formula / weight
C21H32N2O5S · 424.56 g/mol (avg)
Also known as
1-piperidinecarboxylic acid, 3-((methylsulfonyl)amino)-2-(((cis-4-phenylcyclohexyl)oxy)methyl)-, methyl ester, (2r,3s)- · Methyl (2r,3s)-3-((methylsulfonyl)amino)-2-(((cis-4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate · Methyl (2R,3S)-3-[(Methylsulfonyl)Amino]-2-{[(Cis-4-Phenylcyclohexyl)Oxy]Methyl}Piperidine-1-Carboxylate
Code names
TAK-925

Resolves to

Compound
UNII1QMD83K4YNCAS2114324-48-8ChEMBLCHEMBL4650341
Structure
InChIKeyUXZAJSZFFARTEI-YRPNKDGESA-NSMILESCOC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@H](CC1)C1=CC=CC=C1
Targets
O43614HCRTR2

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Danavorexton, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In